VELA Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.3M Sell
29,860
-3,256
-10% -$758K 1.67% 12
2025
Q4
$6.85M Sell
33,116
-4,817
-13% -$953K 1.61% 10
2025
Q3
$7.03M Sell
37,933
-340
-0.9% -$58.3K 1.72% 13
2025
Q2
$5.85M Sell
38,273
-1,123
-3% -$173K 1.59% 12
2025
Q1
$6.53M Buy
39,396
+1,835
+5% +$287K 2.05% 8
2024
Q4
$5.43M Buy
37,561
+6,073
+19% +$941K 1.51% 11
2024
Q3
$5.1M Buy
31,488
+54
+0.2% +$8.6K 1.57% 11
2024
Q2
$4.59M Buy
31,434
+21,371
+212% +$3.18M 1.43% 13
2024
Q1
$1.59M Buy
10,063
+150
+2% +$23.9K 0.54% 60
2023
Q4
$1.55M Buy
9,913
+8
+0.1% +$1.23K 0.59% 50
2023
Q3
$1.54M Buy
9,905
+1,385
+16% +$229K 0.68% 46
2023
Q2
$1.41M Buy
8,520
+134
+2% +$21.6K 0.65% 53
2023
Q1
$1.3M Buy
8,386
+2,355
+39% +$380K 0.59% 56
2022
Q4
$1.07M Hold
6,031
0.53% 65
2022
Q3
$985K Buy
6,031
+3,812
+172% +$645K 0.56% 61
2022
Q2
$394K Buy
+2,219
New +$395K 0.23% 111

Other funds holding JNJ

VELA Investment Management's JNJ Position: Q1 2026 in Review

VELA Investment Management reduced its Johnson & Johnson (JNJ) stake by 9.8% in Q1 2026, selling an estimated $758K and leaving 29,860 shares worth $7.3M. The position accounts for 1.67% of the portfolio, ranked #12.

VELA Investment Management first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • VELA Investment Management held 29,860 shares of Johnson & Johnson worth $7.3M as of Q1 2026.
  • VELA Investment Management sold 3,256 Johnson & Johnson shares in Q1 2026, an estimated $758K.
  • Johnson & Johnson made up 1.67% of VELA Investment Management's portfolio in Q1 2026, its #12 holding.
  • VELA Investment Management first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on VELA Investment Management's 13F filing for Q1 2026, filed 8 May 2026.